Five Rivers RX
  • Home
  • Free Consultation
  • Clients
    • Manufacturers
    • Distributors
      • Drug, Device, and Supply Distributors
      • External Distributors
    • Logistics
    • Providers & Dispensers
  • Services
    • Business Strategy & Consulting
    • Certified Designated Representative Training Courses
    • DEA Compliance
    • FDA Reporting
    • NABP Drug Distributor Accreditation (VAWD)
    • Puerto Rico Services
    • State Compliance Services
      • Initial Assessment
      • Obtaining New Licenses
      • On-going Renewals
      • Quality & Compliance Support
  • Company
    • Leadership
    • Team
    • Careers
    • Testimonials & Accolades
  • Resources
    • Assessments
    • State Regulatory Agencies
    • Webinars
    • Courses
  • Industry Insight & Blog
  • Contact Us
    • Contact Us
    • Our Locations
Select Page
Industry Comments on Iowa’s Drug Distributor Accreditation Requirement

Industry Comments on Iowa’s Drug Distributor Accreditation Requirement

by Five Rivers Rx | Dec 17, 2020 | Industry News

Last month, Iowa became the second of five states to formally recognize/approve the NCDQS QAS Accreditation program, and the first state to approve the program by rule, revising Iowa Code section 17A.8(6). The Maryland Board of Pharmacy approved the NCDQS QAS...
Retail Pharmacy Headwinds: New Technology & Disruption

Retail Pharmacy Headwinds: New Technology & Disruption

by Five Rivers Rx | Nov 19, 2020 | Industry News

The headwinds for retail pharmacy continue to grow as new technology and services are poised to disrupt the dispensing of pharmaceuticals; and COVID-19 is accelerating the developments.   Evolution of Pharmacy In just the past year, there have been various major...
Five Rivers RX Submits Comments on New PR Rule

Five Rivers RX Submits Comments on New PR Rule

by Five Rivers Rx | Nov 5, 2020 | Industry News, Puerto Rico

Five Rivers RX is making public comments on the Puerto Rico Department of Health’s proposed regulation Number 156B titled For the Operation of Establishments that Manufacture, Distribute, and Dispatch Medications in Puerto Rico. Five Rivers RX supports the aim of...
Maryland to Accept NCDQS Accreditation for Licensing Requirements

Maryland to Accept NCDQS Accreditation for Licensing Requirements

by Five Rivers Rx | Oct 22, 2020 | Industry News, Uncategorized

The Maryland Board of Pharmacy became the 4th state to accept NCDQS QAS Accreditation or Inspection program as part of their licensing requirement as of their October 21, 2020 meeting.  Maryland  The Maryland Board of Pharmacy has required out-of-state applicants to...
New York Opioid Treatment Funding: Cut Off One Head, Two Grow Back

New York Opioid Treatment Funding: Cut Off One Head, Two Grow Back

by Five Rivers Rx | Sep 23, 2020 | Industry News

The pharmaceutical supply chain industry is now funding New York’s efforts to combat the opioid crisis through two separate mechanisms. Originally New York state legislature passed the Opioid Stewardship Act (OSA) that was designed to collect $100 million per year for...
Prescription Delivery Gains Startup Community’s Attention

Prescription Delivery Gains Startup Community’s Attention

by Five Rivers Rx | Aug 27, 2020 | Industry News

New headwinds are developing against the independent pharmacy, a business model that is already in a bitter fight against PBMs and payors in the space.   New Entrants in Prescription Delivery Likely the splashiest news, Uber Health announced last week that they...
« Older Entries

Recent Posts

  • Proposed Rules for DEA Suspicious Orders
  • Industry Comments on Iowa’s Drug Distributor Accreditation Requirement
  • NavigateSOM Releases User Manual
  • Retail Pharmacy Headwinds: New Technology & Disruption
  • Five Rivers RX Submits Comments on New PR Rule

Archives

  • January 2021
  • December 2020
  • November 2020
  • October 2020
  • September 2020
  • August 2020
  • July 2020
  • June 2020
  • May 2020
  • April 2020
  • March 2020
  • February 2020
  • January 2020
  • December 2019
  • November 2019
  • October 2019
  • September 2019
  • August 2019
  • July 2019
  • June 2019
  • May 2019
  • April 2019
  • March 2019
  • February 2019
  • January 2019
  • December 2018
  • November 2018
  • October 2018
  • September 2018
  • August 2018
  • July 2018
  • June 2018
  • May 2018
  • April 2018
  • March 2018
  • February 2018
  • January 2018
  • December 2017
  • November 2017
  • October 2017
  • September 2017
  • August 2017
  • June 2017
  • May 2017
  • April 2017
  • March 2017
  • February 2017
  • December 2016
  • November 2016
  • October 2016
  • September 2016
  • August 2016

Categories

  • Competition
  • Compounding Quality Act
  • DEA
  • Drug Importation
  • Drug Manufacturers
  • Five Rivers
  • Industry News
  • NABP
  • NavigateSOM
  • Optum Rx
  • Puerto Rico
  • Regulations
  • Suspicious Order Monitoring
  • Uncategorized
  • VAWD
  • VDIP

Contact Us

 

705 Montgomery Ave., Suite 200
Penn Valley, PA 19072

E: hello@fiveriversrx.com
P: 800.962.8760

Socialize

  • Follow
  • Follow

Subscribe to Our Newsletter

Success!

Subscribe

© 2020 – Five Rivers RX – All rights reserved

 

Subscribe to Our Newsletter